Thomas Stauch/LinkedIn
Jun 13, 2026, 18:21
Thomas Stauch: Discussing the Future of ITP Research and Patient Care
Thomas Stauch, Owner of Hematology and Oncology Practice, Jena, shared a post on LinkedIn:
“One of the best things about EHA is that the conversations often continue beyond the conference itself.
After David Kuter’s excellent presentation on ITP, I had the pleasure of discussing the future of ITP research and patient care with him on the train ride home.
Thank you for the inspiring exchange and valuable insights.”
Stay updated with Hemostasis Today.
-
Jun 13, 2026, 18:25Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
-
Jun 13, 2026, 18:24Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 17:11Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
-
Jun 13, 2026, 16:43Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
-
Jun 13, 2026, 16:21Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026